Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2615 results

Sort By:

The Development, Implementation, and Evaluation of a Social Engagement Support System

Study ID: NCT06913049
Start Date: 2026-03
End Date: 2029-04
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

249660

Intervention / Treatment

Social Engagement Support System

Sponsor

University of Maryland, Baltimore County

Source: clinicaltrials.gov

Share:
Add to list

Neoadjuvant Intra-tumoral RP2 and FLOT in Gastroesophageal Adenocarcinoma

Study ID: NCT07059611
Start Date: 2026-04-01
End Date: 2029-11-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

34

Intervention / Treatment

RP2

5-Fluorouracil

Leucovorin

Oxaliplatin

Docetaxel

Pegfilgrastim

Filgrastim

Surgical Resection of Primary Tumor

Sponsor

Abramson Cancer Center at Penn Medicine

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of Eight-Strand Flexor Tendon Repair Without Splinting

Study ID: NCT07382193
Start Date: 2026-03
End Date: 2027-04
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment
Sponsor

Assiut University

Source: clinicaltrials.gov

Share:
Add to list

Effect of Narrative Education on Glycemic Control in Adults With Type 2 Diabetes in Primary Care

Study ID: NCT07307430
Start Date: 2026-02-15
End Date: 2026-11-15
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

226

Intervention / Treatment

Structured Narrative Education Program

Sponsor

Mustafa Kemal University

Source: clinicaltrials.gov

Share:
Add to list

Navigating the Transition to Adulthood: A Dual Language Mobile App for Latino Youth With ASD and Their Families

Study ID: NCT07170163
Start Date: 2026-06-01
End Date: 2027-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Initiating! mHealth App

Sponsor

The University of Texas Health Science Center, Houston

Source: clinicaltrials.gov

Share:
Add to list

Single-Arm Trial of QL1706, Lenvatinib, and Nab-Paclitaxel for Advanced Refractory Penile Cancer

Study ID: NCT07384416
Start Date: 2026-02-10
End Date: 2031-01-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

47

Intervention / Treatment

QL1706 + Lenvatinib + Nab-Paclitaxel

Sponsor

Sun Yat-sen University

Source: clinicaltrials.gov

Share:
Add to list

A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella Disease and Typhoid Fever in Infants

Study ID: NCT07286370
Start Date: 2026-02-16
End Date: 2028-04-27
Study Type

Interventional

Study Phase

Phase2

No. of Participants

537

Intervention / Treatment

Low dose of iNTS-TCV

Full dose of iNTS-TCV

TYPHIBEV

Prevent 13

Nimenrix

Saline

Sponsor

GlaxoSmithKline

Source: clinicaltrials.gov

Share:
Add to list

Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease

Study ID: NCT06919224
Start Date: 2026-04
End Date: 2032-03
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

287

Intervention / Treatment

mHealth app + booklets

Sponsor

Ohio State University

Source: clinicaltrials.gov

Share:
Add to list

Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma

Study ID: NCT07281417
Start Date: 2026-02-27
End Date: 2033-10-03
Study Type

Interventional

Study Phase

Phase2

No. of Participants

108

Intervention / Treatment

Biopsy Procedure

Biospecimen Collection

Carboplatin

Carboplatin

Cemiplimab

Chemoradiotherapy

Cisplatin

Computed Tomography

Magnetic Resonance Imaging

Paclitaxel

Positron Emission Tomography

Radiation Therapy

Surgical Procedure

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Monitoring Early Response to Targeted Therapy in Stage IV HER2+ Breast Cancer Patients with Advanced PET/MR Imaging

Study ID: NCT04273555
Start Date: 2026-03-01
End Date: 2028-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

[18F]-FDG

Sponsor

University of Alabama at Birmingham

Source: clinicaltrials.gov

Share:
Add to list